News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sundise Chinese Medicine Technology Development Co. Selects Medidata Solutions, Inc. to Drive Entry into U.S. Market


6/11/2010 9:31:57 AM

NEW YORK--(BUSINESS WIRE)--Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, today announced that Traditional Chinese Medicine (TCM) company Sundise will implement Medidata Rave® as its electronic data capture (EDC) and clinical data management (CDM) solution. Selected for its ability to offer a broad global reach with local in-country support, Medidata will work with Sundise to conduct its first U.S. trial for its TCM treatment for liver fibrosis and will play a key role in supporting the company’s strategy to launch in the U.S.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES